These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12756218

  • 1. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
    Nohria A, Garrett L, Johnson W, Kinlay S, Ganz P, Creager MA.
    Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
    [Abstract] [Full Text] [Related]

  • 2. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ, Haynes WG, Hand MF, Webb DJ.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [Abstract] [Full Text] [Related]

  • 3. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC, McG Thom SA, Regan L, Hughes AD.
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [Abstract] [Full Text] [Related]

  • 4. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients.
    Cardillo C, Campia U, Iantorno M, Panza JA.
    Hypertension; 2004 Jan; 43(1):36-40. PubMed ID: 14656951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ.
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [Abstract] [Full Text] [Related]

  • 7. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Hand MF, Haynes WG, Webb DJ.
    Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
    [Abstract] [Full Text] [Related]

  • 8. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A, Jalan R, Newby DE, Johnston NR, Hayes PC, Webb DJ.
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men.
    Westby CM, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA.
    Clin Sci (Lond); 2011 Jun; 120(11):485-91. PubMed ID: 21143196
    [Abstract] [Full Text] [Related]

  • 11. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E, Passauer J, Reimann D, Schulze B, Reichel W, Gross P.
    Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
    [Abstract] [Full Text] [Related]

  • 12. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
    Cardillo C, Kilcoyne CM, Cannon RO, Panza JA.
    Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
    [Abstract] [Full Text] [Related]

  • 13. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis.
    Böhm F, Ahlborg G, Johansson BL, Hansson LO, Pernow J.
    Arterioscler Thromb Vasc Biol; 2002 Apr 01; 22(4):674-9. PubMed ID: 11950709
    [Abstract] [Full Text] [Related]

  • 14. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans.
    McEniery CM, Wilkinson IB, Jenkins DG, Webb DJ.
    Hypertension; 2002 Aug 01; 40(2):202-6. PubMed ID: 12154114
    [Abstract] [Full Text] [Related]

  • 15. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    Silverborn M, Ambring A, Nilsson F, Friberg P, Jeppsson A.
    J Heart Lung Transplant; 2005 Jun 01; 24(6):665-70. PubMed ID: 15949725
    [Abstract] [Full Text] [Related]

  • 16. Vasoconstriction to endogenous endothelin-1 is increased in the peripheral circulation of patients with essential hypertension.
    Taddei S, Virdis A, Ghiadoni L, Sudano I, Notari M, Salvetti A.
    Circulation; 1999 Oct 19; 100(16):1680-3. PubMed ID: 10525485
    [Abstract] [Full Text] [Related]

  • 17. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients.
    Campia U, Cardillo C, Panza JA.
    Circulation; 2004 Jun 29; 109(25):3191-5. PubMed ID: 15148269
    [Abstract] [Full Text] [Related]

  • 18. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
    Helmy A, Newby DE, Jalan R, Hayes PC, Webb DJ.
    Gut; 2003 Mar 29; 52(3):410-5. PubMed ID: 12584225
    [Abstract] [Full Text] [Related]

  • 19. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension.
    Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA.
    Circulation; 2002 Jan 29; 105(4):452-6. PubMed ID: 11815427
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
    Böhm F, Ahlborg G, Pernow J.
    Clin Sci (Lond); 2002 Mar 29; 102(3):321-7. PubMed ID: 11869173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.